ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · H2 FY26

Sheel Biotech H2 FY26 Results: Net Profit ₹11.6 Cr, Down 20.0% YoY

Sheel Biotech Ltd reported revenue from operations of ₹88.2 Cr (-2.5% YoY) and net profit of ₹11.6 Cr (-20.0% YoY) for H2 FY26.

H2 FY26 at a glance · ₹ crore
MetricH2 FY26H1 FY26H2 FY25
Revenue from operations88.221.890.5
Other income0.60.10.5
Total income88.722.090.9
Profit before exceptional items & tax13.80.316.5
Profit before tax13.80.316.5
Net profit11.60.214.5
Operating margin15.6%1.4%18.2%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year-20.00%
Net profit, quarter on quarter+5700.00%
Revenue, year on year-2.50%
Source

NSE results filing, NSE: SHEEL. Figures extracted from the filing.

Read the filing ↗

Sheel Biotech Ltd: key numbers

Share price
₹61.00
Market cap
₹124.2 Cr
Revenue (annual)
₹110.0 Cr
Net profit (annual)
₹11.76 Cr
P/E (TTM)
10.6×Sector 46.8×
Promoter holding
72.31%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sheel Biotech Ltd

All →
18:04 IST NSE
New Order Win

Sheel Biotech Bags ₹14.53 Cr Order

Sheel Biotech Limited has finalised a commercial transaction for its Blueberry project, valued at ₹14.53 Crore. This contract marks a significant business development for the company.

Value
₹14.53 Cr